Evidence map›Paper›PMID 30680577›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2019

Use of MALDI-TOF mass spectrometry to detect nosocomial outbreaks of Serratia marcescens and Citrobacter freundii.

Jürgen Rödel, Alexander Mellmann, Claudia Stein, Monika Alexi, Frank Kipp, Birgit Edel, Kristin Dawczynski, Christian Brandt, Lothar Seidel, Wolfgang Pfister and 2 more

Abstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2026
    Review
  3. Species identification and genotyping ofMicrobiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Molecular Epidemiology of Carbapenem-ResistantInfection and drug resistance · 2026
    Article
  7. Article
  8. Outbreak of NDM-5-ProducingAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  12. Molecular analysis of clinicalFrontiers in microbiology · 2023
    Article
  13. Article
  14. Genetic Characterization ofInfection and drug resistance · 2022
    Article
  15. Article
  16. Review
  17. Characteristics of Isolates ofFrontiers in microbiology · 2021
    Article
  18. Epidemiology and Risk Factors for Carbapenem-ResistantFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jürgen RödelInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany. juergen.roedel@med.uni-jena.de.
Alexander MellmannInstitute of Hygiene, University Hospital Münster, Münster, Germany.
Claudia SteinInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Monika AlexiInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Frank KippInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Birgit EdelInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Kristin DawczynskiUnit Neonatology, Department of Paediatrics, Jena University Hospital, Jena, Germany.
Christian BrandtInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Lothar SeidelbioMérieux, Nürtingen, Germany.
Wolfgang PfisterInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Bettina LöfflerInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Eberhard StraubeInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Jena University Hospital · DEUniversity Hospital Münster · DE

Funding

Bundesministerium f?r Bildung und Forschung 13N13890
6 · The paper itself

Abstract

MALDI-TOF mass spectrometry (MS) may be used as a rapid typing method for nosocomial pathogens. Here, we evaluated MALDI-TOF MS for discrimination of hospital outbreak-related clusters of Serratia marcescens and carbapenemase-producing Citrobacter freundii. Thirty-three S. marcescens isolates collected from neonatal intensive care unit (NICU) patients, and 23 C. freundii isolates including VIM-positive isolates from a hospital colonization outbreak were measured by Vitek MS. Consensus spectra of each isolate were clustered using SARAMIS software. Genotyping was performed by whole-genome sequencing (WGS). First, a set of 21 S. marcescens isolates from 2014 with seven genotypes including three monoclonal clusters was used for the evaluation of MALDI-TOF typing. MS clustering was largely in agreement with genotyping results when the similarity cut-off for clonal identity was set on 90%. MALDI-TOF cluster analysis was then investigated for the surveillance of S. marcescens in the NICU in 2017 and demonstrated the introduction of new strains into the hospital and nosocomial transmissions. MS analysis of the C. freundii outbreak in 2016 revealed a monoclonal cluster of VIM-positive isolates and the separation of epidemiologically non-related VIM-positive and negative isolates. Two additional VIM-positive Citrobacter isolates from food samples were closely related to the large monoclonal cluster. WGS confirmed the MS results. MALDI-TOF MS may be used as a first-line typing tool for S. marcescens and C. freundii to detect transmission events in the hospital because isolates of an identical WGS type were grouped into the same MS cluster.

Indexed as

Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnti-Bacterial AgentsBacterial ProteinsBacterial Typing Techniquesbeta-LactamasesCitrobacter freundiiCross InfectionDisease OutbreaksEnterobacteriaceae InfectionsGermanyHumansIntensive Care Units, NeonatalMicrobial Sensitivity TestsSerratia marcescensWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCitrobacter freundiiMALDI-TOFSerratia marcescensTypingWhole genome sequencing

Identifiers

PMID30680577
OpenAlexW2913986294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.